ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: "Nanosphere, Inc." (NSPH) Report Updated: May 23, 2016 | Print This Page

Get more stock ratings by Louis Navellier

"Nanosphere, Inc." (NSPH)

Rating: Sell Volatility: Moderate
Total Grade: D Industry: Biotechnology
Competitors: EBS,LOXO,EXEL,AVXL

Stock Analysis

Rating: Monthly View

A
B
C
D
F
May June July August September October November December January February March April

Rating: Weekly View

This Week: D down upgrade
Last Week: N same no change
Two Weeks Ago: N up no change
service keys

"Nanosphere, Inc."© quotemedia

Company Profile

Nanosphere, Inc. develops, manufactures, and markets molecular diagnostic tests for infectious diseases and associated drug resistance markers for earlier disease detection, optimal patient treatment, and improved healthcare economics. It offers a molecular diagnostics platform, Verigene System platform that enables sensitive genomic and protein testing on a single platform. The Verigene System includes a bench-top molecular diagnostics workstation and single use consumable for on demand testing. The Verigene System is used for testing infectious disease assays, human and pharmacogenetic assays, and ultra-sensitive and multiplexed protein assays. The company focuses on serving hospital-based laboratories and academic research institutions in the United States. Nanosphere, Inc. was founded in 1998 and is headquartered in Northbrook, Illinois.